GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (FRA:AQA) » Definitions » Days Sales Outstanding

Advanced Medical Solutions Group (FRA:AQA) Days Sales Outstanding : 65.63 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Advanced Medical Solutions Group Days Sales Outstanding?

Advanced Medical Solutions Group's average Accounts Receivable for the six months ended in Dec. 2023 was €26.3 Mil. Advanced Medical Solutions Group's Revenue for the six months ended in Dec. 2023 was €73.3 Mil. Hence, Advanced Medical Solutions Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 65.63.

The historical rank and industry rank for Advanced Medical Solutions Group's Days Sales Outstanding or its related term are showing as below:

FRA:AQA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.48   Med: 59.13   Max: 91.02
Current: 60.74

During the past 13 years, Advanced Medical Solutions Group's highest Days Sales Outstanding was 91.02. The lowest was 43.48. And the median was 59.13.

FRA:AQA's Days Sales Outstanding is ranked better than
54.43% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.77 vs FRA:AQA: 60.74

Advanced Medical Solutions Group's Days Sales Outstanding increased from Dec. 2022 (55.26) to Dec. 2023 (65.63).


Advanced Medical Solutions Group Days Sales Outstanding Historical Data

The historical data trend for Advanced Medical Solutions Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group Days Sales Outstanding Chart

Advanced Medical Solutions Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.16 94.67 57.30 52.31 55.60

Advanced Medical Solutions Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.11 62.10 55.26 60.55 65.63

Competitive Comparison of Advanced Medical Solutions Group's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Days Sales Outstanding falls into.



Advanced Medical Solutions Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Advanced Medical Solutions Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (20.362 + 24.269) / 2 ) / 146.499*365
=22.3155 / 146.499*365
=55.60

Advanced Medical Solutions Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (28.427 + 24.269) / 2 ) / 73.269*365 / 2
=26.348 / 73.269*365 / 2
=65.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group  (FRA:AQA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Advanced Medical Solutions Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group (FRA:AQA) Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.

Advanced Medical Solutions Group (FRA:AQA) Headlines

No Headlines